http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201910774-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39827c7f0e28af1bc11de7b735f2ddee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddd81b7f80159626dfb4b02a4d80b2a4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2018-06-28^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8aecd8870aae9304bf31322dd16ce06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a6b2a26d29b99e95b685429f25dc6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07d82c93fd4c2dcfc62e3a837882510 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5027c4db8b2782f6dd1d289be461e3 |
| publicationDate | 2019-03-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201910774-A |
| titleOfInvention | Gene marker, reagent group and pancreatic cancer detection method for detecting pancreatic cancer |
| abstract | The invention relates to a gene marker, a reagent group and a pancreatic cancer detection method for detecting pancreatic cancer. Gene markers include one or more of the following genes: maltase, C-type exogenous lectin family 4 member C, sorting protein 7, interstitial homeobox 2, FAT atypical cadherin 1, flavin Monooxygenase 3, cystic fibrosis transmembrane conductance regulator, phospholipase phosphatase-related protein 3, alpha albumin, and collagen type V alpha2 chain; 5-hydroxymethyl in pancreatic cancer gene markers detected by high-throughput sequencing Cytosine content to determine the presence of pancreatic cancer. The method for detecting pancreatic cancer has the advantages of being safe and non-invasive, wide source of DNA, high accuracy, convenient operation, and good experience of the subject. The invention can be combined with other clinical indicators to provide more accurate judgments for screening, diagnosis, treatment and prognosis of pancreatic cancer. |
| priorityDate | 2017-08-04^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 153 of 153.